Health
Targeted treatments for EGFR-positive lung cancer can improve outcomes – Medical News Today
Targeted therapies are available for people with EGFR mutations, and they tend to be more effective. Learn more about the treatment…
EGFR mutations account for about 1015% of lung cancer cases in the United States. Biomarker testing allows oncologists to choose targeted treatments for these types of lung cancer.
Non-small cell lung cancer (NSCLC) accounts for about 85%
of lung cancer…
Continue Reading